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Summary
Background:  Osteoporosis  has  been  described  as  a  progressive  skeletal  disorder  until  a  patient
experiences  a  fragility  fracture.  The  number  of  patients  with  osteoporotic  fractures  is  increasing
at an  exponential  rate.  Orthopaedic  surgeons,  most  of  the  time,  ﬁrst  clinicians  seen  by  patients
at the  time  of  fracture,  do  not  routinely  consider  osteoporosis  management.  Therefore,  we
compared  the  knowledge  of  orthopaedic  surgeons  and  internists  regarding  medical  treatment
required:  which  group  would  have  more  abilities  to  keep  patients  with  osteoporotic  fractures
under management?
Hypothesis:  We  hypothesize  that  internists  may  have  more  abilities  to  assess  and  treat  osteo-
porosis for  patients  with  osteoporotic  fractures;  therefore,  referring  these  patients  to  this
specialized team  for  post-fracture  medical  consultation  is  required.
Methods:  A  questionnaire  composed  of  seven  closed  questions  was  administered  to  4700
orthopaedic  surgeons  and  internists.  This  question  list  addressed  the  orthopaedic  surgeons’
and internists’  knowledge  in  managing  patients  with  osteoporotic  fractures.  The  questions  were
designed in  a  way  to  cover  the  topics  of  diagnosis,  treatment,  and  approach  to  an  osteoporotic
patient with  osteoporotic  fractures.
Results:  In  this  survey,  3431  respondents  were  included.  Only  118  (fewer  than  10%)  orthopaedic
surgeons would  order  bone  mineral  densitometry  (BMD)  in  osteoporotic  fractures  in  contrast
to 1544  (79%)  internists.  Approximately  1485  (76%)  internists  against  487  (33%)  orthopaedic
surgeons  prescribe  proper  dosage  of  calcium  and  vitamin  D.
Conclusion:  Typical  orthopaedic  surgeon  is  not  naturally  inclined  to  manage  patients  with  osteo-
porotic fractures.  The  existing  management  gap  between  the  occurrence  of  an  osteoporotic
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fracture  and  the  identiﬁcation  and  treatment  of  osteoporosis  requires  multifaceted  interven-
tion. Improved  communication  between  orthopaedic  surgeons  and  internists  may  reduce  this
gap between  fracture  occurrence  and  osteoporosis  management.
Level  of  evidence:  Level  III  prospective  diagnostic  study.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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steoporosis  has  been  described  as  a  progressive  skele-
al  disorder  until  an  individual  experiences  an  osteoporotic
racture,  typically  occurring  at  the  wrist,  vertebra  or  the
ip  [1].  In  addition,  osteoporotic  fracture  has  been  identi-
ed  as  the  only  clinically  relevant  marker  of  bone  quality.
hese  fractures  typically  occur  when  an  individual  experi-
nces  a  low-energy  trauma  like  falling  from  a  standing  height
r  less  and  even  vertebral  fractures  often  occur  without  a
raumatic  event  [2].  According  to  previous  studies,  after
he  age  of  40  years,  a  history  of  an  osteoporotic  fracture
ncreases  the  risk  of  a  secondary  fracture  by  two-  to  nine-
old  and  can  be  a  good  predictor  of  a  subsequent  low-energy
racture  [3,4].  The  number  of  patients  with  osteoporotic
ractures  who  are  hospitalized  is  increasing  at  an  exponen-
ial  rate  [5—7]  thus  in  view  of  this  critical  health  issue,  it
s  necessary  to  question  how  we  can  ensure  appropriate
edical  management  of  patients  with  these  osteoporotic
ractures.
Investigations  have  revealed  inadequate  osteoporosis
valuation  and  treatment  following  osteoporotic  fractures
8—16].  A  large  retrospective  cohort  survey  in  the  United
tates  found  that  only  2.8%  of  women  with  osteoporotic
ractures  underwent  densitometry  and  22.9%  were  pre-
cribed  osteoporosis  treatment  [9].  It  is  now  well  established
hat  management  of  osteoporosis  is  effective  in  preventing
ubsequent  osteoporotic  fractures  in  high-risk  populations
16—27].  Also  it  has  been  shown  that  the  timely  initiation  of
reatment  following  an  osteoporotic  fracture  can  increase
one  mineral  density  and  lower  fracture  risk  within  months
28—33].
Among  orthopaedic  surgeons  and  internists  worldwide,
nterest  is  growing  in  the  investigation  and  treatment  of
steoporosis  in  patients  who  have  sustained  an  osteoporotic
racture.  As  orthopaedic  surgeons  are  generally  the  ﬁrst
hysicians  to  evaluate  and  treat  patients  with  an  osteo-
orotic  fracture;  therefore,  it  seems  that  they  may  have
 unique  opportunity  to  alter  long-term  health  outcomes
i.e.,  the  prevention  of  subsequent  fracture)  by  referring
he  patient  or  by  personally  initiating  identiﬁcation  and
reatment  of  osteoporosis.  Despite  the  increasing  momen-
um  in  the  academic  orthopaedic  surgeon  community  for
rthopaedic  surgeons  to  become  more  involved  in  general
ith  facilitating  medical  treatment  of  their  patients  with  an
steoporotic  fracture,  it  is  unclear  how  strongly  orthopaedic
urgeons  consider  treating  these  patients,  whether  they
onsider  initiating  medical  management  of  patients  with
n  osteoporotic  fracture  to  be  a  necessary  extension  of
heir  responsibilities  [34].  Of  surgeons  who  had  ‘‘extensive’’
nvolvement  in  treating  patients  with  osteoporotic  frac-
ures,  78%  strongly  agreed  that  expansion  of  their  practice
t
a
0nto  non-surgical  domains  such  as  management  of  osteo-
orosis  would  be  appropriate.  However,  previous  surveys
ave  demonstrated  that  the  proportion  of  osteoporotic
racture  patients  who  receive  appropriate  osteoporosis
iagnosis  and  treatment  is  low  [8—11,15,16,35—40]  and
rthopaedic  surgeons  still  neglect  to  investigate,  assess
nd  treat  such  patients  for  osteoporosis.  Similarly,  Hajc-
ar  et  al.  [36]  in  a  cohort  of  108  patients  with  a  history
f  an  osteoporosis  fracture  treated  in  an  Ontario  frac-
ure  clinic  showed  that  less  than  20%  of  patients  were
iagnosed  with  osteoporosis;  fewer  received  appropriate
herapy.
The  aim  of  this  survey  was  to  compare  the  knowledge
nd  ability  of  orthopaedic  surgeons  and  internists  in  the
anagement  of  osteoporosis  in  patients  who  experience
n  osteoporotic  fracture.  Our  hypothesis  was  that  many
rthopaedic  surgeons  do  not  consider  osteoporosis  man-
gement  to  be  inextricably  linked  to  the  surgical  care  of
atients  with  an  osteoporotic  fracture.  The  present  study
as  conducted  in  order  to  assess  and  compare  the  knowl-
dge  of  orthopaedic  surgeons  and  internists  regarding  the
edical  treatment  of  their  patients  with  osteoporotic  frac-
ures,  in  order  to  ﬁnd  which  groups  have  more  abilities  to
eep  on  management  of  patients  with  osteoporotic  frac-
ures.
aterial and methods
aterial
he  data-collection  period  for  this  study  spanned  from
anuary  2010  to  February  2011,  and  it  continued  until  a
ufﬁciently  rich  description  of  the  concept  under  study  was
chieved.  A  survey  composed  of  seven  closed  questions  was
dministered  by  our  research  team  to  4700  orthopaedic
urgeons  and  internists.  The  invited  orthopaedic  surgeons
nd  internists  in  the  questionnaire  group  were  chosen
andomly  from  Pubmed  database.  This  questionnaire  had
nitially  been  pre-tested  and  validated  before  being  used
hrough  our  osteoporosis  care  team.  The  questions  were
esigned  in  a way  to  cover  the  topics  of  diagnosis,  treat-
ent,  and  approach  to  an  osteoporotic  patient  with  an
steoporotic  fracture.  The  content  of  the  study  was  devel-
ped  from  a  systematic  literature  review  and  the  data
ere  obtained  from  postal  questionnaires  with  orthopaedic
urgeons  and  internists.  The  form  of  the  survey  questions
nd  responses  were  patterned  in  accordance  with  multiple-
hoice  questions.  The  results  were  compiled  5  months  after
he  ﬁrst  mailing.  The  reliability  of  the  questions  has  been
ssessed  by  Cronbach’s  alpha;  its  values  ranged  from  0.72  to
.91.
o
A
r
2
1
(
a
rAbility  in  managing  patients  with  osteoporotic  fractures  
Methods
Provided  questions  addressed  the  respondent’s  knowledge
about  osteoporotic  fractures  and  underlying  osteoporosis
care  as  well  as  opinions  regarding  appropriate  treat-
ment  interventions  and  related  responsibilities.  The  mailing
addresses  of  the  surveyed  clinicians  were  obtained  from
their  articles  published  in  Pubmed.  The  questionnaire  was
sent  to  orthopaedic  surgeons  and  internists  with  a  transmit-
tal  letter.  No  distinction  was  made  regarding  sex  or  whether
a  clinician  was  in  an  urban  or  rural  area,  in  private  practice,
w
s
t
Table  1  Number  of  orthopaedic  surgeons  and  internists  responde
Number  of  orthopaedic  surg
USA  First  Email  17  
Second Email  11  
Canada First  Email  7  
Second Email  3  
Brazil First  Email  1  
Second Email 2  
Germany First  Email  8  
Second Email 9  
France First  Email 8.5  
Second Email 12  
Italy First  Email 3.5  
Second Email 4.5
Spain  First  Email 4  
Second Email 6  
Austria First  Email 2  
Second Email 3  
Sweden First  Email 3  
Second Email  2  
England First  Email  4  
Second Email  10  
Portugal First  Email  3.5  
Second Email  5  
Turkey First  Email  1  
Second Email  0.5  
Belgium First  Email  0.5  
Second Email  0.5  
Iran First  Email  1.5  
Second Email  3  
China First  Email  13.5  
Second Email  7  
Japan First  Email  6  
Second Email  4  
South Korea  First  Email  5  
Second Email  2  
New Zealand  First  Email  1  
Second Email  3  
South Africa  First  Email  2  
Second Email  4  
Australia First  Email  4.5  
Second Email 4  
Russia First Email  2.5  
Second Email  4  
Morocco First  Email  1  
Second Email  0.5  725
r  at  an  academic  center.  The  surveys  were  ﬁrst  mailed  in
pril,  and  a  second  mailing,  to  the  non-responders,  was  car-
ied  out  one  month  later.  Of  the  4700  surveys  that  were  sent,
475  completed  surveys  (1004  orthopaedic  surgeons  and
485  internists)  were  returned  in  the  ﬁrst  communication
Table  1).  The  responders  were  offered  no  remuneration.  To
ssess  possible  differences  between  the  responders  and  non-
esponders,  surveys  were  resent  to  the  non-responders  along
ith  a  transmittal  letter  from  the  principal  investigator  that
tated  the  importance  of  the  study  and  that  completion  of
he  survey  was  essential  to  ensure  the  statistical  reliability
d  the  respective  questionnaire.
eons  responded  (%)  Number  of  internists  responded  (%)
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f  the  study.  Nine  hundred  and  ﬁfty-six  additional  surveys
ere  obtained  from  the  group  of  clinicians  who  had  not
esponded  to  the  previous  mailings.  Of  the  4700  surveys  that
ere  sent,  3431  completed  surveys  were  returned  (a  73%
esponse  rate).
tatistics
ll  statistical  analyses  were  done  using  the  SPSS  soft-
are.  The  data  were  summarized  using  descriptive  statistics
mean  ±  SD,  number  of  patients  per  category,  etc.).  t-test
nd  Chi-square  were  used  to  compare  the  data  obtained.
esults
f  the  2190  orthopaedic  surgeons  invited,  1477  orthopaedic
urgeons  (81%  male  and  19%  female)  averaging  43  years  in
ge  (range:  32—68  years  old)  and  a  mean  of  14  years  of
xperience  (range:  5—27  years)  were  compared  with  1954
nternists  (among  2510  internists  invited)  who  responded
48%  male  and  52%  female)  and  had  a  mean  age  of  41  years
ld  (range:  32—69  years  old)  averaging  12  years  of  expe-
ience  (range:  4—30  years).  No  signiﬁcant  difference  was
ound  between  mean  age  and  mean  work  years  experience
etween  the  two  groups  (P  >  0.05).
In  this  survey,  only  15%  of  the  orthopaedic  surgeons  and
5%  of  the  internists  agreed  with  high  dose  of  vitamin  D
njection  after  stabilization  in  a  patient  with  osteoporotic
ractures.  Although  densitometry  is  reported  as  being  acces-
ible,  in  all  departments,  fewer  than  10%  of  the  orthopaedic
urgeons  in  contrast  to  79%  of  the  internists  would  order
one  mineral  densitometry  (BMD)  in  osteoporotic  fractures.
owever,  the  knowledge  in  dosage  of  medications  is  differ-
nt  between  orthopaedic  surgeons  and  internists;  although
pproximately  76%  of  the  internists  prescribe  1200  mg/kg
alcium  and  1000  IU/day  vitamin  D,  orthopaedic  surgeons
elieved  in  different  dosages  which  are  not  indicated  in
revious  studies;  as  the  other  result  showed  about  bisphos-
honate  dosages  in  prevention  (5  mg  per  day)  and  treatment
10  mg  per  day)  [16].  If  falling  is  supposed  in  a patient,
2%  of  the  internists  would  refer  to  the  respective  team
o  manage  falling.  According  to  the  questionnaire,  if  a
atient  presented  with  an  osteoporotic  fracture  who  is
nder  corticosteroid  therapy  for  a  long  time,  91%  of  the
nternists  would  order  BMD  compared  with  a  much  smaller
ercentage  of  the  orthopaedic  surgeons  (8%).  Approximately
4%  of  the  orthopaedic  surgeons  and  83%  of  the  internists
elt  knowledgeable  in  managing  osteoporosis  according  to
MD  interpretation  as  they  refer  well-known  osteoporotic
atients  to  internists  as  an  orthopaedic  surgeon  and  assess
nd  treat  secondary  cause  of  osteoporosis  as  an  internist
Table  2)  (Fig.  1).
iscussion
he  present  survey  reﬂects  the  current  status  of  orthopaedic
urgeons  and  internists  approaches  to  osteoporosis  in
atients  with  osteoporotic  fractures.  A  study  of  two  groups
f  3431  orthopaedic  surgeons  (43%)  and  internists  (57%)
1477  orthopaedic  surgeons  and  1954  internists  among  2190
t
p
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rthopaedic  surgeons  and  2510  internists  responded  the
uestionnaire,  respectively)  showed  orthopaedic  surgeons
ypically  are  not  inclined  in  the  management  of  osteo-
orosis  in  patients  with  osteoporotic  fractures.  Most  of  the
rthopaedic  surgeons  displayed  a general  lack  of  motivation
o  refer  these  patients  to  the  respective  team  for  post-
racture  medical  consultation.  In  addition,  the  results  of  this
tudy  show  that  internists  may  have  more  abilities  to  assess
nd  treat  osteoporosis  of  patients  with  osteoporotic  frac-
ures,  so  by  playing  a  major  coordinating  role  an  internist
s  able  to  ensure  that  the  osteoporotic  fracture  patient
eceives  appropriate  non-surgical  treatment  and  care  in
ddition  to  the  fracture  management.
We  note  limitations  to  our  study.  First,  endocrinologists
nd  rheumatologists  were  not  included.  Second,  in  this  sur-
ey  we  have  selected  orthopaedic  surgeons  and  internists
rom  the  various  health  systems  and  organisations  among
he  whole  world.  Although  this  variety  in  managing  osteo-
orosis  in  different  countries  could  be  a  limitation  of  this
urvey,  it  would  not  be  a  confounder  to  the  conclusion.  By
he  way,  according  to  previous  studies,  under-management
f  osteoporosis  is  a  big  challenge  in  different  health  care
ystems.
Despite  the  evidence  in  support  of  detecting  and  treat-
ng  patients  for  osteoporosis  after  they  have  sustained  an
steoporotic  fracture,  only  a  small  proportion  of  patients
ith  osteoporotic  fractures  are  receiving  appropriate  osteo-
orosis  care  [40],  in  addition  up  to  95%  of  patients  are
ischarged  without  adequate  determination  of  the  cause
f  the  fracture.  Some  published  reports  [9,11,15,16,35—38]
emonstrate  that  the  majority  of  patients  with  recent  frac-
ures  have  not  been  assessed  for  low  BMD.  According  to  the
ther  study,  barriers  to  osteoporosis  care  for  osteoporosis
racture  patients  include  time  of  identiﬁcation  and  treat-
ent,  concerns  about  the  effectiveness  of  treatments  and
ack  of  clarity  about  who  is  responsible  for  the  initiation  and
anagement  of  these  medications  [34]. Obviously,  in  2012,
orbi  and  Aghamirsalim  [41]  reveal  that  the  majority  of
rthopaedic  surgeons  responded  lack  of  sufﬁcient  training  in
steoporosis.  This  is  reﬂected,  subjectively  and  objectively,
y  inappropriate  knowledge  on  osteoporosis  management  in
ost  cases;  therefore,  it  is  easy  to  dismiss  the  underlying
ause  of  osteoporotic  fractures.
The  polling  results  demonstrate  that  the  orthopaedic
urgeons  representatives  who  participated  have  proba-
ly  already  positively  selected  themselves  and  consider
hat  they  are  currently  engaged  or  ready  to  engage  in
steoporosis  management  for  patients  with  osteoporotic
ractures;  therefore,  the  real  lack  of  knowledge  about
steoporosis  is  most  likely  underestimated  as  results  indi-
ated  that  internists  are  highly  aware  of  osteoporosis  care
n  osteoporotic  fracture  patients  and  largely  positive  about
articipation  in  care.  In  this  context,  it  may  be  reason-
ble  to  promulgate  an  active  role  for  orthopaedic  surgeons
n  initiation  of  early  management  of  osteoporosis.  Such
ctivity,  without  an  appropriate  referring  or  consulting  with
nternists  [25],  could  result  in  substantial  complications;
herefore,  orthopaedic  surgeons’  awareness  could  improve
he  osteoporosis  management  rate  in  patients  with  osteo-
orotic  fractures  [21].
The  main  message  of  this  study  is  that  despite  the  avail-
bility  of  a  number  of  therapeutic  options,  many  patients
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Table  2  Results  of  the  seven  closed  questions.
Orthopaedic  surgeons Internists  P-value
Correct  answer  (%) Wrong  answer  (%) Correct  answer  (%) Wrong  answer  (%)
1  A  63-year-old  woman  with  a  family  history  of  maternal  hip
fracture  and  complaint  of  subtrochantric  fracture  was
presented.  Patient  was  stable.  Orthopaedic  surgeon
injected  the  patient  with  50,000  IU  vitamin  D
15  85  25  75  0.1
2 A  65-year-old  man  with  a  hip  fracture  was  candidate  for
operation  treatment.  The  patient  was  operated
successfully.  What  would  you  suggest  in  the  next  step?
8  92  79  21  <  0.05
3 A  52-year-old  woman  with  a  wrist  fracture  was  presented
to your  department.  If  you  found  out  that  she  had  had  an
osteoporotic,  what  dosage  of  calcium  and  vitamin  D  would
you prescribe  after  surgery?
33  67  76  24  <  0.05
4 In  previous  section,  what  dosage  of  Bisphosphonate  would
you prescribe  for  prevention  and  treatment  of  an
osteoporotic  fracture?
25  75  67  33  <  0.05
5 A  73-year-old  man  with  a  previous  vertebral  fracture  was
presented  to  your  ofﬁce  for  follow-up.  The  mechanism  of
his fracture  was  falling.  What  would  you  suggest  in  the  next
step?
29  71  72  28  <  0.05
6 A  54-year-old  man  (a  known  case  of  rheumatoid  arthritis)
has been  prescribed  prednisolone  5  mg  per  day  for
6 months.  He  was  presented  with  a  fracture  in  his  distal
right radius.  What  would  you  suggest  in  the  next  step?
8  92  91  9  <  0.05
7 A  74-year-old  woman  with  a  history  of  subtrochantric
fracture  was  hospitalized.  The  BMD  test  revealed  -3  and  -5
as T-score  and  Z-score,  respectively.  What  would  you
suggest  in  the  next  step?
14  86  83  17  <  0.05
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rigure  1  Survey  questions  and  respondents  (black  columns  ar
re percent  of  the  internists’  responses).ith  osteoporotic  fractures  do  not  undergo  appropriate
steoporosis  care,  and  are  at  high  risk  for  subsequent
ractures.  The  existing  management  gap  between  the  occur-
ence  of  an  osteoporotic  fracture  and  the  identiﬁcation  and
t
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arcent  of  the  orthopaedic  surgeons’  responses  and  gray  columnsreatment  of  osteoporosis  requires  multifaceted  interven-
ion  in  order  to  reduce  the  incidence  of  future  fracture.
mproved  communication  between  orthopaedic  surgeons
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